Introduction
The autosomal-dominant tumor syndrome tuberous sclerosis (TSC) is characterized by the development of tumors, named hamartomas, in the kidneys, heart, skin and brain. The latter often cause seizures, mental retardation and a variety of developmental disorders, including autism (Kwiatkowski, 2003) . The tumor suppressor gene TSC1 on chromosome 9q34 encodes hamartin (The TSC1 Consortium, 1997) and TSC2 on chromosome 16p13.3 encodes tuberin (The European Chromosome 16 Tuberous Sclerosis Consortium, 1993) . TSC patients carry a mutant TSC1 or TSC2 gene in each of their somatic cells and loss of heterozygosity has been documented in a wide variety of TSC tumors. Inactivation of TSC1 and TSC2 causes a similar phenotype (Kwiatkowski, 2003; Astrinidis and Henske, 2005) .
Tuberin and hamartin form a heterodimer. Hamartin stabilizes tuberin by inhibiting its interaction with the HERC1 ubiquitin ligase (Chong-Kopera et al., 2006) . Tuberin has been implicated in the regulation of different cellular functions, such as endocytosis (Xiao et al., 1997) , transcription (Henry et al., 1998) or neuronal differentiation (Soucek et al., 1998a) . Tuberin and hamartin also regulate cell cycle progression. Tuberin binds to the cyclin-dependent kinase inhibitor p27 and, thereby, prevents p27 degradation via its SCF-type E3 ubiquitin ligase complex (Soucek et al., 1997 (Soucek et al., , 1998b Miloloza et al., 2000; Rosner et al., 2003; .
Studies in Drosophila and mammalian cells demonstrated that the TSC protein complex antagonizes the mammalian target of rapamycin (mTOR) and p70S6K (S6K) signaling network -which has a central role in the regulation of cell growth in response to growth factors, cellular energy and nutrient levels. In this pathway, insulin and insulin-like growth factors phosphorylate and activate their cognate tyrosine kinase receptors (INRs), triggering the recruitment and phosphorylation of insulin receptor substrates, to generate a docking site at the membrane for the phosphatidylinositide-3 0 -OH kinase (PI3K). Phosphorylation of the membrane lipid phosphatidylinositol 4,5-biphosphate by PI3K produces the second messenger phosphatidylinositol 3,4,5-triphosphate, which activates Akt. Akt is one of the several kinases that phosphorylate tuberin. Tuberin is phosphorylated by Akt on S939 and T1462, and through an unknown mechanism; this phosphorylation inhibits the ability of tuberin to act as a GTPase-activating protein against Rheb (Ras homolog enriched in brain), which in turn regulates mTOR. Accordingly, Akt is assumed to stimulate mTOR signaling by inhibiting the function of tuberin (Dan et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002) . mTOR phosphorylates S6K on T389, which correlates with the activation of S6K (Dufner and Thomas, 1999 ; for detailed reviews of the role of tuberin in the mTOR/S6K cascade, see Li et al., 2003; Pan et al., 2004; Astrinidis and Henske, 2005) . In agreement with the postulated cascade described above, it was found that overexpression of tuberin suppresses phosphorylation of S6K on residue T389 (representing S6K activity) (Dan et al., 2002; Goncharova et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002; Tee et al., 2002) . mTOR regulates translation via S6K and 4E-BP1. S6K is considered to be involved in translation control of a small subset of mRNAs that contain a 5 0 -terminal oligopyrimidine tract. Cap-dependent translation is facilitated by mTOR phosphorylation and inactivation of 4E-BPs, which are suppressors of eIF4E. eIF4E regulates initiation of translation of specific mRNAs (Wullschleger et al., 2006) . Thus, it is anticipated that mTOR localizes in the cytoplasm resulting in signals from the upstream components, PI3K and Akt, both of which also localize to the cytoplasm, to the downstream targets S6K and 4E-BP, also localized to the cytoplasm. However, nuclear eIF4E has been suggested to be involved in nuclear functions, including splicing (Lejbkowicz et al., 1992; Dostie et al., 2000) . Besides regulation of translation, mTOR has also been implicated in the regulation of ribosome biogenesis, macroautophagy or transcription (Wullschleger et al., 2006) . In fact, mTOR and its substrate S6K have been found to be localized to both the cytoplasm and nucleus, and cytoplasmic-nuclear shuttling of mTOR has been shown to be involved in rapamycin-sensitive signaling and translation initiation (Kim and Chen, 2000; Zhang et al., 2002; Bachmann et al., 2006) . Very recently, it was demonstrated that the components (and their activities) of the entire PI3K-Akt-mTOR-S6K pathway are localized to both the cytoplasm and nucleus (Furuya et al., 2006) .
A definitive subcellular localization has not been established yet for either hamartin or tuberin. Tuberin has been reported to be cytoplasmic, to be localized to the Golgi apparatus and to the nucleus. The TSC protein complex has also been detected at centrosomes (Wienecke et al., 1996; Nellist et al., 1999; Lou et al., 2001; Astrinidis and Henske, 2005; Astrinidis et al., 2006) .
Here, we demonstrate that the tuberin-mediated regulation of S6K can be detected in the cytoplasm and in the nucleus. We further report that phosphorylation by Akt triggers delocalization of tuberin from the nucleus to the cytoplasm. We found nuclear localization of tuberin to occur in G0-arrested cells with low Akt activity and to disappear upon cell cycle re-entry accompanied by induction of Akt activity.
Results
The role of S939 and T1462 phosphorylation for tuberin's potentials to regulate S6K and p27 To investigate the role of Akt phosphorylation, we made use of the TSC2 SATA mutant harboring mutations of the major Akt phosphorylation sites S939 and T1462 . Western blot analyses using antibodies specific for phospho-tuberin S939 and for phospho-tuberin T1462 confirmed that the ectopic TSC SATA mutant, in contrast to wild-type (wt) TSC2, is not phosphorylated on these sites. Phosphorylation of TSC2 wt on S939 and on T1462 can be upregulated by cooverexpression of activated Akt, whereas the TSC2 SATA mutant remained unphosphorylated, even under high Akt activity. Ectopic expression of a dominantnegative Akt mutant diminished tuberin phosphorylation on T1462 (Figure 1a) . To confirm the specificity of this experiment, FLAG-tagged TSC wt and FLAGtagged TSC2 SATA were immunoprecipitated using anti-FLAG antibody. Western blot analysis of S939 phosphorylation again confirmed that TSC2 SATA is not phosphorylated, even not under high ectopic Akt activity (Figure 1b) . Phosphorylation of tuberin on S939 and T1462 by Akt is known to downregulate its potential to inhibit S6K activity (see Introduction). Accordingly, the TSC2 SATA mutant harbors a higher potential to regulate S6K activity. Western blot analyses using antibodies specific for phospho-S6K T389 (representing the active S6K) or specific for phospho-S6 protein (an S6K target) confirmed that the SATA mutant mediates stronger negative effects on S6K activity than TSC2 wt (Figure 1c and d ). These data demonstrate the TSC2 SATA mutant to be an optimal tool to analyse the role of Akt phosphorylation for different functions of tuberin.
Ectopic tuberin triggers an increase of the intracellular amounts of p27 protein (see Introduction). In addition, tuberin causes nuclear localization of p27 (Soucek et al., 1998b; Pasumarthi et al., 2000) . Assuming that phosphorylation on S939 or T1462 by Akt also negatively affects tuberin's potential to regulate p27, the SATA mutants should mediate stronger effects than TSC2 wt. Although ectopic overexpression of TSC2 wt confirmed the already known effects on p27 protein levels and on p27 localization, our experiments revealed that the TSC2 SATA mutant does not trigger stronger effects, neither on upregulation of total p27 protein amounts (Figure 2a and b) nor on nuclear induction of p27 (Figure 2c and d) . Taken together, these data demonstrate that Akt phosphorylation of S939 and T1462 does not negatively regulate tuberin's potential to regulate p27, although this phosphorylation downregulates its effects on S6K.
Akt downregulates nuclear localization of tuberin
We wanted to further elucidate the role of Akt phosphorylation for tuberin regulation. Overexpression of activated Akt triggers an increase of tuberin phosphorylation of S939 and T1462 (Figure 1a) . Under the chosen experimental conditions, endogenous tuberin protein levels remained unaffected, even under very high ectopic amounts of active Akt (Figure 3a) . Next, we wanted to investigate whether Akt phosphorylation has any influence on the cytoplasmic/nuclear localization of tuberin. In agreement with earlier studies (Wienecke et al., 1996; Lou et al., 2001; Astrinidis and Henske, 2005) , we found tuberin to be localized to both the cytoplasm and nucleus. In logarithmically growing cells, ectopic tuberin is localized predominantly to the cytoplasm, with a significant proportion of nuclear tuberin. Upon overexpression of activated Akt, cytoplasmic tuberin increases and nuclear tuberin decreases (Figure 3b ). In addition to the analysis of ectopic tuberin, we next wanted to confirm these effects studying endogenous tuberin. Akt also mediates an upregulation of cytoplasmic and a downregulation of nuclear endogenous tuberin. To allow comparison of the effects on ectopic and on endogenous tuberin, fractionated protein extracts of both type of experiments were analysed on the same gel. The different tuberin amounts made it necessary to present different exposures of this analysis to allow for such a comparison (Figure 3c ). These data demonstrate that Akt mediates delocalization of endogenous tuberin and even of high amounts of ectopic tuberin.
The results described above were obtained via inducing high levels of Akt-mediated phosphorylation of tuberin (compare the tuberin phosphorylation status in Akt-overexpressing cells presented in Figure 1a ). To Logarithmically growing HEK293 cells were transiently transfected with mammalian expression vectors, either empty as a control, or harboring FLAG-tagged full-length wt TSC2, the FLAG-tagged TSC2 SATA mutant, myc-tagged activated Akt, or the myc-tagged dominant-negative Akt mutant K179M. Western blot analyses were performed using antibodies specific for tuberin, phospho-tuberin S939, phospho-tuberin T1462, Akt and a-tubulin. Short exposures not presenting endogenous tuberin are shown to allow comparison of S939 and T1462 phosphorylation of wt tuberin and SATA tuberin transfectants, with and without ectopic co-expression of Akt. (b) Cell transfections were performed as described above. Ectopic tuberin was immunoprecipitated using anti-FLAG antibody. S939 phosphorylation was analysed by immunodetection using anti-phospho-tuberin S939 antibody and anti-tuberin antibody. (c) HEK293 cells were transfected with mammalian expression vectors, either empty as a control, or harboring FLAG-tagged full-length wt TSC2, the FLAG-tagged TSC2 SATA mutant, or HA-tagged S6K. Western blot analyses were performed using antibodies specific for phospho-S6K T389, HA-tagged S6K, tuberin and a-tubulin. A short exposure not presenting T389 phosphorylation of endogenous S6K is shown to allow better comparison of T389 phosphorylation of ectopic HA-tagged S6K. Phospho-S6K T389 signals were densitometrically scanned and normalized to the HA-S6K signals. (d) HEK293 cells were transfected with empty vector control, FLAG-TSC2wt or FLAG-TSC2 SATA. S6 phosphorylation status, tuberin and a-tubulin were analysed by immunoblotting. Phospho-S6 signals were densitometrically normalized to a-tubulin signals.
Nuclear/cytoplasmic localization of tuberin M Rosner et al analyse more physiological conditions, we next wanted to study the effects of downregulation of endogenous intracellular Akt activity. We made use of the dominantnegative Akt mutant, which we found to downregulate endogenous Akt to phosphorylate tuberin on T1462 ( Figure 1a ). First, we wanted to confirm that this dominant-negative mutant mediates opposite effects on the mTOR/S6K cascade compared to activated Akt wt. Whereas overexpression of activated Akt wt increased the phosphorylation status of the S6K target S6, ectopic expression of the dominant-negative Akt mutant decreased the phosphorylation of S6 about 10-fold ( Figure 4a ). With regard to tuberin localization, the dominant-negative Akt mutant also triggered opposite effects compared to Akt wt. We found slightly decreased cytoplasmic tuberin and over twofold increased nuclear tuberin upon transfection with the dominant-negative Akt mutant (Figure 4b ). To further confirm that phosphorylation by Akt triggers downregulation of nuclear tuberin localization, we tested whether mutations of the Akt phosphorylation sites S939 and T1462 would mediate affects on tuberin localization. In agreement with the findings described above, we observed increased nuclear localization of the TSC2 SATA mutant compared to wt TSC2 ( Figure 4c ). Next, we investigated the phosphorylation of tuberin S939 and T1462 by Akt in the cytoplasm and in the nucleus. Western blot analyses on cytoplasmic and nuclear fractions revealed that Akt activity (represented by phospho-Akt S473) is higher in the cytoplasm than in the nucleus. We also found the phosphorylation of tuberin by Akt to be higher in the cytoplasm than in the nucleus ( Figure 4d ). As we found Akt phosphorylation to control tuberin localization, these results suggest that Akt phosphorylation diminishes the nuclear import of tuberin. However, we cannot exclude that regulation of nuclear export also plays a role. Akt has been shown to be involved in the regulation of both nuclear import and nuclear export (see also Discussion). Taken together, these data show that Akt is a physiological regulator of tuberin localization.
Tuberin inhibits S6K activity in both the cytoplasm and nucleus To further investigate the biological relevance of the observed Akt-mediated tuberin translocation, it was important to test whether tuberin is functionally active in both compartments, the cytoplasm and the nucleus. The tuberin target mTOR and its substrate S6K are localized to both the cytoplasm and nucleus (Kim and Chen, 2000; Zhang et al., 2002; Bachmann et al., 2006; Furuya et al., 2006) . Cells treated with the mTOR inhibitor rapamycin were fractionated. Western blot analysis of phospho-S6K T389 demonstrated downregulation of S6K activity via inhibition of mTOR to occur in the cytoplasm and in the nucleus (Figure 5a ). These data confirm that mTOR can inhibit S6K activity in both compartments under the chosen experimental conditions. Ectopic tuberin is also localized to both compartments (Figure 3c ). These findings made it possible to test whether ectopic tuberin can Nuclear/cytoplasmic localization of tuberin M Rosner et al downregulate S6K activity in the cytoplasm and in the nucleus. Fractionation experiments revealed that tuberin triggers downregulation of S6K activity in both compartments ( Figure 5b ). Upon Akt expression, nuclear localization of ectopic tuberin is downregulated (Figure 3c ). Accordingly, the effects of ectopic tuberin on nuclear S6K should also be diminished in Aktoverexpressing cells. In fractionation experiments after co-overexpression of tuberin and Akt, we really found diminished nuclear effects of tuberin on S6K (compare densitometrical analyses in Figure 5b and in Figure 5c ). To analyse more physiological conditions, we next wanted to study the effects of downregulation of endogenous intracellular tuberin. Human embryonic kidney (HEK) 293 cells were treated with small interfering RNA (siRNA) specific for TSC2. Fractionation experiments and Western blot analyses demonstrated that siRNA treatment triggers downregulation of tuberin in the cytoplasm and in the nucleus (Figure 6a ). Furthermore, this downregulation of tuberin protein levels leads to the upregulation of S6K activity in both compartments (Figure 6b ). These data demonstrate that under physiological conditions, tuberin is a negative regulator of S6K activity in both the cytoplasm and nucleus. Accordingly, tuberin is functional in both compartments. This finding allows the conclusion that Akt-mediated localization controls the intracellular distribution of tuberin activity between the cytoplasm and nucleus.
Regulation of Akt activity and tuberin localization
Akt activity is known to be regulated upon mitogenic stimuli/cell cycle progression (Wullschleger et al., 2006) . As we found Akt to regulate tuberin localization, it was of interest to compare the regulation of endogenous Akt activity and tuberin localization during mitogenic stimulation/cell cycle progression.
Logarithmically growing NIH3T3 cells (log) were serum-starved (ss) and restimulated with serum. This approach confirmed that cyclin D1 and cyclin A protein levels are induced during the transition to the S phase. Akt activity (detected by phospho-Akt S473) of logarithmically growing cells is downregulated upon serum starvation in G0 cells. Serum-induced re-entry into the cell cycle immediately triggers a strong Nuclear/cytoplasmic localization of tuberin M Rosner et al induction of Akt activity. In agreement with the data described above, fractionation experiments revealed that tuberin is predominantly cytoplasmic in logarithmically growing cells. In serum-arrested G0 cells with downregulated Akt activity, a significant proportion of tuberin is localized to the nucleus. Upon re-entry into the cell cycle, nuclear localization of tuberin is downregulated parallel to the activation of Akt. As already reported (Soucek et al., 1997; Miloloza et al., 2000; Manning et al., 2002) , the total tuberin protein amount is constant (Figure 7 ). To confirm that nuclear localization of tuberin is downregulated upon serum stimulation with another experimental approach, we performed immunofluorescent staining. G0 arrest upon serum starvation was proven by accumulation of nuclear p27 (Figure 8a ) and nuclear localization of tuberin was found to be downregulated upon serum restimulation (Figure 8b ).
These data are in perfect agreement with the abovereported finding that Akt phosphorylation negatively regulates tuberin's nuclear localization. We here propose a new model suggesting that in G0 cells low Akt activity allows nuclear localization of tuberin. Upon mitogenic stimulation, Akt activity is induced via the insulin signaling pathway and nuclear tuberin localization is downregulated. Figure 4 Akt phosphorylation of tuberin S939/T1462 regulates its nuclear/cytoplasmic localization. (a) HEK293 cells were transiently transfected with mammalian expression vectors, either empty as a control, or harboring myc-tagged-activated Akt, or the myc-tagged dominant-negative Akt mutant K179M. The ectopic Akt proteins, the phospho-S6 status and a-tubulin protein levels were analysed by Western blotting of total lysates. Densitometrical analyses allowed normalization of the phospho-S6 signals to a-tubulin. (b) HEK293 cells were transfected as described above. Fractions containing cytoplasmic or nucleoplasmic protein were isolated. Each fraction was analysed for tuberin protein levels via Western blotting. Purity of fractions was proven by co-analysing topoisomerase IIb (nuclear) and a-tubulin (cytoplasmic). Densitometrical analyses allowed normalization of cytoplasmic tuberin signals to a-tubulin and of nuclear tuberin signals to topoisomerase IIb. (c) Logarithmically growing HEK293 cells were transfected with mammalian expression vectors, either empty as a control, or harboring FLAG-tagged full-length wt TSC2, or the FLAG-tagged TSC2 SATA mutant. Fractions containing cytoplasmic or nucleoplasmic protein were isolated. Each fraction was analysed for ectopic FLAG-tagged tuberin protein levels and total tuberin (short and long exposure) via Western blotting. Purity of fractions was proven by co-analysing topoisomerase IIb (nuclear) and a-tubulin (cytoplasmic). (d) HEK293 cells were transfected with FLAG-TSC2wt and fractions containing cytoplasmic or nucleoplasmic protein were isolated. Western blot analyses were performed using antibodies specific for tuberin, phospho-tuberin S939, phospho-tuberin T1462, Akt, phospho-Akt S473, topoisomerase IIb and a-tubulin (asterisks indicate unspecific bands). Signals were densitometrically analysed. Nuclear protein levels are given as fold change of cytoplasmic protein levels set to 1.
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Discussion
Tuberin is an important regulator of the activity of the cyclin-dependent kinase inhibitor p27 and of the mTOR/S6K cascade (Soucek et al., 1998b; Li et al., 2003; Pan et al., 2004; Astrinidis and Henske, 2005) . Whereas for the latter, it has been shown that Akt-mediated phosphorylation of S939 and T1462 negatively regulates tuberin's activity (Dan et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002) , it remained unclear whether this Akt phosphorylation also negatively affects tuberin's potential to regulate p27. It was the aim of this study to further elucidate the role of Akt phosphorylation for tuberin regulation. We here found that under the same experimental conditions, mutations of S939 and T1462 positively regulate tuberin's potential to control S6K, but do not positively affect tuberinmediated regulation of p27 protein levels. This demonstrates that p27 protein regulation is not a consequence of tuberin's potential to affect mTOR/S6K and that regulating p27 protein amounts and mTOR/S6K are separable functions of tuberin. Recently, we have identified the molecular mechanism how tuberin regulates p27 protein levels. Tuberin binds to the cyclindependent kinase inhibitor p27 and, thereby, prevents p27 degradation via its SCF-type E3 ubiquitin ligase complex ). The molecular mechanism of tuberin-mediated p27 localization is currently under investigation in our laboratory.
Tuberin has been shown to be phosphorylated also by other kinases. 5 0 AMP-activated protein kinase, a sensor of cellular energy status, phosphorylates tuberin at T1227 and S1345 and thereby activates tuberin to downregulate S6K activity . The Raf-MEK1/2-ERK1/2 signaling cascade leads to the phosphorylation of tuberin S664 by ERK1/2 and the consequent functional inactivation of TSC1/TSC2 to regulate S6K (Ma et al., 2005) . In addition, the MAPKactivated kinase, p90 ribosomal S6 kinase (RSK) 1, was found to phosphorylate and inactivate tuberin at S1798 (Roux et al., 2004) . The role of these phosphorylations for tuberin's potential to regulate Skp2-mediated p27 degradation or p27 localization has not been clarified. It has earlier been shown that a TSC2 gene harboring mutations of the Akt phosphorylation sites S939 and T1462, the RSK1 phosphorylation site S1798, together with other mutated phosphorylation sites S981, T993, S1130 and S1132 loses its ability to stabilize p27 (Dan et al., 2002) . Accordingly, it will be of great interest for the future to investigate the phosphorylation events that control tuberin's potential to regulate p27. This study (Dan et al., 2002) also reports that under high ectopic Akt activity, the effects of tuberin on p27 stability are diminished. As both tuberin and p27 are targets of Akt (Dan et al., 2002; Fujita et al., 2002; Inoki et al., 2002; Liang et al., 2002; Manning et al., 2002; Potter et al., 2002; Shin et al., 2002; Viglietto et al., 2002) and we found that Akt phosphorylation of tuberin on S939 and T1462 does not affect its potential to regulate p27 protein amounts, it will also be of interest for the future Figure 5 Tuberin inhibits S6K in the cytosol and in the nucleus. (a) HEK293 cells were transfected with HA-tagged S6K and treated with the mTOR inhibitor rapamycin. Fractions containing cytoplasmic or nucleoplasmic protein were isolated. Each fraction was analysed for S6K T389 phosphorylation status and S6K protein levels via Western blotting. Purity of fractions was proven by coanalysing topoisomerase IIb (nuclear) and a-tubulin (cytoplasmic). (b) HEK293 cells were transfected with FLAG-tagged full-length wt TSC2 and HA-tagged S6K. Fractions containing cytoplasmic or nucleoplasmic protein were isolated. Each fraction was analysed for S6K T389 phosphorylation status and S6K protein levels via Western blotting. Purity of fractions was proven by co-analysing topoisomerase IIb (nuclear) and a-tubulin (cytoplasmic). Densitometrical analyses allowed normalization of phospho-S6K T389 signals to S6K protein signals. (c) HEK293 cells were transfected as described above and co-transfected with myc-tagged-activated Akt. Cytoplasmic and nucleoplasmic fractions were analysed for S6K T389 phosphorylation status and S6K protein levels. Purity of fractions was proven by co-analysing topoisomerase IIb and a-tubulin. Densitometrical analyses allowed normalization of phospho-S6K T389 signals to S6K protein signals.
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Tuberin has been shown to be localized to the cytoplasm and the nucleus (Wienecke et al., 1996; Lou et al., 2001; Astrinidis and Henske, 2005) . Phosphorylation by Akt can regulate protein localization via affecting either nuclear import or nuclear export. For example, Akt has been shown to regulate the nuclear/ cytoplasmic localization of p27 (Fujita et al., 2002; Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) . Accordingly, it was interesting to investigate the role of Akt phosphorylation in tuberin localization. In the literature, reports can be found describing that ectopic Akt triggers downregulation of tuberin protein amounts (Dan et al., 2002; Liu et al., 2006) , whereas others describe tuberin protein levels to remain unaffected by Akt (Manning et al., 2002) . Importantly, although Akt activity is known to be induced upon mitogenic stimulation (Wullschleger et al., 2006) , tuberin protein amounts are constant (Soucek et al., 1997; Miloloza et al., 2000; Manning et al., 2002) . Under the experimental conditions used here, we found that high ectopic Akt activity does not affect tuberin protein expression. Furthermore, tuberin protein levels were confirmed to remain constant in cells, in which Akt activity was strongly regulated upon mitogenic stimulation. However, we found that high amounts of ectopicactivated Akt increase the phosphorylation of tuberin S939 and T1462 and downregulate nuclear localization of endogenous tuberin as well as of ectopic tuberin. Downregulation of phosphorylation of tuberin via a dominant-negative Akt mutant mediated the opposite effects on the localization of endogenous tuberin. A TSC2 mutant, which cannot be phosphorylated on S939 Figure 6 Downregulation of endogenous tuberin triggers activation of cytoplasmic and nuclear S6K activity. (a) HEK293 cells were treated with siRNA specific for TSC2. Downregulation of tuberin expression was proven in total lysates, cytoplasmic and nuclear extracts. To allow a better visualization of the levels of tuberin downregulation, a slightly longer exposure was chosen for nuclear extract analysis than for the cytoplasmic analysis. (b) HEK293 cells were transfected with HA-tagged S6K and treated with siRNA specific for TSC2. Cytoplasmic and nucleoplasmic fractions were analysed for tuberin, S6K T389 phosphorylation status, S6K, topoisomerase IIb and a-tubulin. Densitometrical analyses allowed normalization of phospho-S6K T389 signals to S6K protein signals. Figure 7 Cell cycle regulation of endogenous Akt activity and tuberin localization. (a) Logarithmically growing NIH3T3 fibroblasts (log) were arrested by serum starvation for 48 h (ss). At the indicated time points of serum restimulation, cells were harvested and cytofluorometrically analysed for DNA distribution. (b) Cyclin D1, cyclin A, phospho-Akt S473 (representing Akt activity), Akt and tuberin was analysed by Western blotting. In addition, fractions containing cytoplasmic or nucleoplasmic protein were isolated. Each fraction was analysed for tuberin protein levels via Western blotting. Purity of fractions was proven by co-analysing c-jun (nuclear) and a-tubulin (cytoplasmic). and T1462, showed increased nuclear localization. These findings demonstrate Akt phosphorylation to be a physiological regulator of tuberin localization.
Tuberin is a multifunctional protein, which is involved in the regulation of cell size, cell cycle, translation, transcription and cell differentiation (Kwiatkowski, 2003; Astrinidis and Henske, 2005) . A wide variety of proteins, implicated in different regulations, have been demonstrated to interact with tuberin. Besides typical cytoplasmic proteins, such as, for example, all isoforms of the mammalian 14-3-3 protein family, tuberin was also shown to bind to nuclear proteins, such as, for example, the cell cycle molecules cyclin B1 or cyclin-dependent kinase 1 (reviewed by . The here demonstrated Aktcontrolled nuclear/cytoplasmic localization of tuberin could provide an additional mechanism to regulate tuberin's activities and interactions with their binding partners. One could speculate that induction of Akt activity upon mitogenic stimulation triggers downregulation of tuberin's nuclear localization freeing tuberinblocked nuclear activities, which could be important regulators of cell cycle entry. We have already reported that loss of tuberin is sufficient to drive a G0-arrested cell into the cell cycle (Soucek et al., 1997) .
At this point, it was important to investigate two questions: (1) Is tuberin functionally active in both compartments, the cytoplasm and the nucleus? (2) Is tuberin's nuclear localization regulated upon mitogenic stimulation in negative correlation to the activity of Akt? To answer the first question, we tested whether tuberin can downregulate S6K activity in both compartments. S6K regulation is a major function of tuberin (Li et al., 2003; Pan et al., 2004) and the mTOR/S6K cascade has been shown to be active in the cytoplasm and in the nucleus (Kim and Chen, 2000; Zhang et al., 2002; Bachmann et al., 2006; Furuya et al., 2006) . We found ectopic overexpression of tuberin to decrease S6K activity and downregulation of endogenous tuberin via siRNA to increase S6K activity in both compartments. These data demonstrate tuberin to be a physiological regulator of cytoplasmic and nuclear S6K activity.
Serum restimulation experiments of arrested cells allowed answering the second question. In logarithmically growing cells with high Akt activity, tuberin is predominately localized to the cytoplasm. In G0-arrested cells, Akt activity is downregulated and a significant proportion of tuberin can be detected in the nucleus. Upon mitogenic restimulation into the cell cycle, Akt activity is induced and nuclear localization of Nuclear/cytoplasmic localization of tuberin M Rosner et al tuberin is downregulated. These findings are in perfect agreement with our model of Akt-mediated tuberin localization. The elucidation of tuberin's functions and targets, specifically localized to the cytoplasm or to the nucleus, will be of great intrigue for the future. This will not only allow a further understanding of the tumor suppressor function of tuberin, but will also provide further insights into the intracellular functions and roles of Akt.
Materials and methods
Cells, cell culture and flow cytometry HEK293 cells and NIH3T3 cells (mouse fibroblasts) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% calf serum and antibiotics (30 mg/l penicillin, 50 mg/l streptomycin sulfate). All cultures were kept at 371C and 5% CO 2 and routinely screened for mycoplasma. For cell cycle synchronization, NIH3T3 cells were starved in DMEM containing 0.5% serum for 48 h and restimulated by the addition of DMEM containing 10% fetal calf serum. For cytofluorometric analyses of DNA distribution, cells were harvested by trypsinization and fixed by rapid submersion in ice-cold 85% ethanol. After overnight fixation at À201C, cells were pelleted by centrifugation and DNA was stained in an appropriate amount of staining solution containing 0.25 mg/ml propidium iodide, 0.05 mg/ml RNase, 0.1% Triton X-100 in citrate buffer, pH 7.8. DNA distribution was analysed on a Beckton Dickinson FACScan using Modfit Analysis software (BD Biosciences, San Jose, CA, USA). To block intracellular mTOR activity, rapamycin was added to the culture medium at a concentration of 100 nM 24 h before harvest.
Transfections
For transient transfections, the following plasmids were used: FLAG-tagged TSC2wt (human), FLAG-tagged TSC2 SATA mutant (S939A/T1462A) , myc-tagged Akt (activated mouse Akt), myc-tagged Akt K179M (dominant-negative mouse Akt) (Upstate Biotechnologies, Charlottesville, VA, USA), HA-tagged p70S6K or empty vector controls. Lipofectamine 2000 (Invitrogen, Lofer, Austria) was used as transfection reagent following the transfection protocol provided by the manufacturers (compare also Rosner et al., 2003) .
siRNA treatment specific for TSC2 RNA silencing was achieved using human TSC2 siRNA (Cell Signaling, Danvers, MA, USA) at a final concentration of 50 nM. siRNA was delivered to the cells using Lipofectamine 2000 reagent (Invitrogen), following the transfection protocol provided by the manufacturers.
Nuclear and cytoplasmic fractionation Adherent cells were washed twice with phosphate-buffered saline (PBS), collected by scraping and pelleted by centrifugation. Cell pellets were lysed in five packed cell volume buffer F1 containing 20 mM Tris (pH 7.6), 50 mM 2-mercaptoethanol, 0.1 mM ethylenediaminetetraaceticacid (EDTA), 2 mM MgCl 2 and 1 mM phenylmethylsulfonyl fluoride (PMSF), supplemented with protease inhibitors (2 mg/ml aprotinin, 2 mg/ml leupeptin, 0.3 mg/ml benzamidinechloride and 10 mg/ml trypsin inhibitor) for 2 min at room temperature and subsequent incubation on ice for 10 min. Thereafter, NP-40 was added at a final concentration of 1% (v/v) and lysates were homogenized by passing through a 20 G needle for three times. Nuclei were pelleted by centrifugation at 600 g for 5 min at 41C and supernatant containing cytoplasmic proteins was collected and stored at À801C. Remaining nuclei were washed three times in buffer F1 containing 1% NP-40. During the last wash, nuclei were stained with Trypan blue and microscopically examined for number, purity and integrity. The nucleic pellets were lysed in buffer containing 20 mM HEPES (pH 7.9), 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM PMSF, 0.5 mM NaF, 0.5 mM Na 3 VO 4 and 0.5 mM dithiothreitol, supplemented with protease inhibitors (see above) by repeated freezing and thawing. Supernatants containing soluble nucleic proteins were collected by centrifugation at 25 000 g for 20 min and stored at À801C (Lou et al., 2001 ).
Immunoblotting and immunoprecipitation
For preparing total lysates, cells were washed with PBS, collected by scraping and lysed in buffer containing 20 mM HEPES (pH 7.9), 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM PMSF, 0.5 mM NaF and 0.5 mM Na 3 VO 4 , supplemented with 2 mg/ml aprotinin, 2 mg/ml leupeptin, 0.3 mg/ml benzamidinchlorid and 10 mg/ml trypsin inhibitor by repeated freezing and thawing. Supernatants were collected by centrifugation and stored at À801C. Protein concentrations were determined using the Bio-Rad protein assay with bovine serum albumin as the standard. Proteins were run on an sodium dodecyl sulfatepolyacrylamide gel and transferred to nitrocellulose. Blots were stained with Ponceau-S to visualize the amount of loaded protein (Rosner et al., 2003) . For immunodetection, antibodies specific for the following proteins were used: tuberin (C-20, Santa Cruz, Santa Cruz, CA, USA), phospho tuberin (S939) (Cell Signaling), phospho tuberin (Thr1462) (Cell Signaling), Akt (Cell Signaling), phospho Akt (S473) (Cell Signaling), phospho-(Ser/Thr) Akt substrate (Cell Signaling), p70S6K (Cell Signaling), phospho p70S6K (Thr389) (Cell Signaling), c-jun (H-79, Santa Cruz), c-myc (9E10; Pharmingen, San Diego, CA, USA), cyclin A (H-432, Santa Cruz), cyclin D1 (M-20, Santa Cruz), p27 (C-19, Santa Cruz), p27 (57, Transduction Laboratories, San Diego, CA, USA), topoisomerase IIb (Transduction Laboratories), a-tubulin (Ab-1, Calbiochem, Darnstadt, Germany), FLAG (M2, Sigma, Vienna, Austria) and HA (3F10, Roche, Vienna, Austria). Signals were detected with appropriate horseradish peroxidase-conjugated secondary antibodies and the enhanced chemiluminescence method.
For immunoprecipitations, proteins were prepared as described above. Briefly, crude cell extracts were precleared with 40 ml Protein G-Sepharose beads for 30-60 min at 41C and incubated with the primary anti-FLAG antibody (M2, Sigma). After complex formation at 41C (at least for 2 h), immunoprecipitates were washed twice with buffer containing 50 mM Tris-Cl (pH 8.0), 1% NP-40, 150 mM NaCl, 10 mM b-glycerophosphate, 1 mM NaF, 0.1 mM Na 3 VO 4 and 0.2 mM PMSF, supplemented with protease inhibitors. Western blot analysis and the antibodies used for immunodetection are described above.
Immunofluorescent staining NIH3T3 cells were seeded onto chamber slides, washed with PBS, fixed in 4% paraformaldehyde for 10 min at room temperature, treated with 0.1% Triton X-100 for 15 min and blocked for nonspecific binding in PBS containing 3% non-fat, dry milk for another 30 min. After 1 h incubation with anti-p27 antibody (57, Transduction Laboratories) or anti-tuberin antibody (C-20, Santa Cruz), positive cells were visualized by incubation with the secondary antibodies Alexa Fluor 488 goat anti-mouse IgG or Alexa Fluor 488 goat anti-rabbit IgG (Molecular Probes Invitrogen), respectively. After washing in PBS, slides were rinsed in 4 0 ,6 0 -diamidino-2-phenylindolestaining solution (1 mg/ml).
Statistical analyses
The significance of the observed differences was determined by Student's t-test (paired, two-tailed) using Graph-Pad INSTAT software. P-values >0.05 are defined as not significant.
